Stoke Therapeutics director Alexander Cumbo files initial beneficial ownership statement
STOK•Stoke Therapeutics director Alexander Cumbo filed an initial Form 3 on Sept. 25, 2026.
1. Ownership filing
Cumbo filed an initial Form 3 on Sept. 25, 2026.
